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ABSTRACT
Objective: The objective of this study is to investigate
the relationship between cotinine level-confirmed
secondhand smoke (SHS) exposure and glycemic
parameters and obesity.
Research design and methods: We examined a
cohort of 6472 adults from the National Health and
Nutrition Examination Surveys, 1999–2010. Serum
cotinine levels and self-reported data on smoking were
used to determine smoking status. The outcome
variables were body mass index (BMI) and glycemic
status (HbA1c), Homeostasis Model Assessment of
Insulin Resistance (HOMA-IR), and fasting plasma
glucose (FPG). Descriptive, bivariate, and multivariate
analyses were conducted.
Results: Using cotinine level-confirmed smoking
status, 1794 (27.4%) of the sample were current
smokers, 1681 (25.0%) were former smokers, 1158
(17.8%) were secondhand smokers, and 1839 (29.8%)
were non-smokers. In a generalized linear model after
controlling for potential confounding variables,
secondhand smokers had higher adjusted levels of
HOMA-IR, FPG, and BMI compared with non-smokers
(p<0.05). Adjustment for BMI demonstrated that some,
but not all, of the detrimental effects of SHS on
glycemic parameters are mediated by the increased
body weight of secondhand smokers.
Conclusions: We conclude that SHS is associated
with obesity and worsening glycemic parameters. More
studies are needed to show a causal relationship
between SHS and glycemic parameters and to
understand the mechanisms involved in the
association.
INTRODUCTION
In 2011, 43.8 million people or 19.0% of all
adults (aged 18 years and older) in the USA
smoked cigarettes.1 During 2000–2004, an
estimated 443 000 persons in the USA died
prematurely each year as a result of the
health consequences of smoking or exposure
to secondhand smoke (SHS),2 making it the
single most preventable cause of death. SHS
is classified by the US Environmental
Protection Agency (EPA) as a ‘known human
carcinogen’.3 Cigarette smoking and type 2
Significance of this study
What is already known about this subject?
▪ Studies have shown a positive association
between cigarette smoking and the incidence of
diabetes mellitus (DM).
▪ A recent meta-analysis examining prospective
cohort studies on passive smoking (by history)
showed a significant relative risk of developing
DM.
What are the new findings?
▪ Cotinine level-confirmed secondhand smoke (SHS)
is associated with a higher rate of Homeostasis
Model Assessment of Insulin Resistance (HOMA-
IR), hemoglobin A1c, fasting plasma glucose as
well as obesity after correcting for confounders.
▪ Adjustment for body mass index demonstrated
that some, but not all of the detrimental effects
of SHS on glycemia are mediated by the
increased body weight of secondhand smokers.
▪ The percentage of participants who were classi-
fied as secondhand smokers using our definition
decreased between 1999–2000 and 2009–2010,
which demonstrates that smoke-free laws are
effective and may help decrease the number of
Americans who develop obesity and DM as a
result of being exposed to SHS.
How might these results change the focus of
research or clinical practice?
▪ Our study showing the association between
cotinine-verified secondhand smokers and wor-
sening of glycemic parameters as well as obesity
prompts the need for reliable and cost-effective
methods for interventions to prevent secondhand
smoking including stronger smoke-free laws.
▪ Future research studies are needed to show a
causal relationship between SHS and glycemic
parameters and to understand the mechanisms
involved in the association.
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diabetes mellitus (DM) are major public health con-
cerns and both are risk factors for cardiovascular
disease, with an increased mortality rate among female
smokers who have DM.4 Studies have shown the associ-
ation between cigarette smoking and an increased risk
of developing type 2 DM,5 an association that is surpris-
ing as smokers are leaner than non-smokers and obesity
is positively associated with DM.6
SHS is responsible for about 46 000 deaths per year
from heart disease in current non-smokers.7 According
to the US Department of Health Services, exposure to
SHS causes lung cancer in non-smoking adults.8
Exposure to SHS can be tested by measuring the
amount of cotinine (a breakdown product of nicotine)
in a non-smoker’s blood, saliva, or urine.9 Studies have
shown the association of cotinine with an increased level
of hemoglobin A1c (HbA1c) (a measurement of gly-
cemic exposure) in subjects without DM.10 Multiple
studies have shown a positive association between cigar-
ette smoking and the incidence of DM,5 and a recent
meta-analysis examining prospective cohort studies on
passive smoking (by history) showed a significant relative
risk of developing DM;11 the relationship between
cotinine-verified SHS and DM is less established. As the
development of DM is clearly related to obesity,6 we also
wanted to examine the relationship between SHS and
obesity and if obesity influences the relationship
between SHS and glycemic parameters. In our study, we
tested the association between SHS, confirmed by serum
cotinine levels, and glycemic parameters and obesity.
RESEARCH DESIGN AND METHODS
Study design
We used data from the National Health and Nutrition
Examination Survey (NHANES), a cross-sectional survey
conducted by the National Center for Health Statistics,
using a stratified multistage probability sample to obtain
a representative sample of the total civilian, non-
institutionalized US population.12 Since 1999, the
NHANES has released data at 2-year intervals. NHANES
collected questionnaire data during a face-to-face home
interview followed by a physical examination and add-
itional interviews administered in a specially equipped
mobile examination center where blood samples were
drawn, from which serum cotinine and glycemic levels
were determined. We combined data using six successive
waves of NHANES data (1999–2010) for our analyses.
Our analytical sample was 6472 adults 20 years and older
(figure 1) who had complete data on recent self-
Figure 1 Flow chart depicting
six successive waves of NHANES
cycle (1999–2010). NHANES,
National Health and Nutrition
Examination Survey.
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reported cigarette smoking status and had serum coti-
nine levels measured. Participants with missing data on
any of the study variables were excluded from the ana-
lysis. We excluded 627 subjects who were taking insulin
or other antiglycemic medications, as these medications
would not allow us to determine the true effect of
primary or SHS on glycemic outcomes. Participants who
used other nicotine products such as pipes, snuff, patch,
gum, cigars, or chewed tobacco, either alone or with
cigarettes were also excluded from the analysis, as we
were concerned about confounding effects of these
products (figure 1).
Definition of variables and laboratory measurements
Obesity
Body weight and height were measured according to
standard techniques during the examinations and body
mass index (BMI) was calculated as weight in kilograms
divided by the square of height in meters.13 Participants
with BMI 25–29.9 kg/m2 were classified as overweight
and those with BMI≥30 kg/m2 were classified as
obese.14
Glycemic status
Glycemic status was assessed by measures based on
Homeostasis Model Assessment of Insulin Resistance
(HOMA-IR),15 fasting plasma glucose (FPG, mg/dL),
and HbA1c (%). FPG was measured in participants who
were examined in the morning session after an 8–
24-hour fast using the hexokinase enzymatic reference
method (Roche Diagnostics, Indianapolis, IN). Serum
insulin was measured by means of a radioimmunoassay
(Pharmacia Diagnostics, Uppsala, Sweden). All measure-
ments were performed at the University of Missouri—
Columbia School of Medicine Department of Child
Health, Diabetes Reference Laboratory, Columbia,
Missouri (David Goldstein, MD, Director). HOMA-IR
was determined according to the following equation:
fasting plasma glucose (mmol/L) × fasting plasma
insulin (µU/mL)/22.5).15 HbA1c was measured on all
participants using the boronate affinity high perform-
ance liquid chromatography (HPLC) system. We categor-
ized normal values for HOMA-IR as <2.2, for HbA1c as
<6.5%, and for FPG as <126 mg/dL.16 17
Cotinine level-confirmed smoking status
Cotinine is a metabolite of nicotine that is used as a
marker for active and passive smoking. Serum cotinine
was measured by an isotope dilution-high performance
liquid chromatography/atmospheric pressure chemical
ionization tandem mass spectrometry (ID HPLC-APCI
MS/MS). The racial/ethnic cut-offs for cotinine categoriza-
tion by Benowitz et al18 were used to categorize individuals
as non-smokers (NS) (cotinine <0.05 ng/mL, all races/
ethnicities), secondhand smokers (SHSers) (cotinine
0.05–5.91 ng/mL for non-Hispanic blacks; 0.05–4.84 ng/
mL for non-Hispanic whites, and 0.05–0.83 ng/mL
for Hispanics), and current smokers (CS) (cotinine
≥5.92 ng/mL, 4.85 ng/mL, and 0.84 ng/mL for non-
Hispanic blacks, non-Hispanic whites, and Hispanics,
respectively). As Benowitz et al18 did not define a cut-off
for Hispanics, we used the Mexican-American cut-off for
Hispanics.
We categorized smoking status according to two
methods, that is, one based on the objective cotinine
levels as defined above and a second method based on a
combination of cotinine status and response to specific
questions. In the second method, CS were defined as
those who smoked at least a 100 cigarettes in lifetime
AND responded ‘Everyday’ or ‘Some days’ to ‘Do you
now smoke’. Former smokers (FS) were defined as those
who smoked at least a 100 cigarettes in lifetime AND
responded ‘Not at all’ to Do you now smoke” AND also
responded ‘No’ to smoking cigarettes in last 5 days.
SHSers were defined as (1) those who responded ‘no’ to
‘Smoking at least 100 cigarettes in lifetime’ AND ‘No’ to
smoking cigarettes in last 5 days AND had cotinine
<0.05 ng/mL AND answered ‘Yes’ to the question ‘Were
you exposed to cigarettes at home/work?’ OR (2) those
who responded ‘No’ to ‘Smoking at least 100 cigarettes
in lifetime’ AND ‘No’ to smoking cigarettes in last 5 days
AND had cotinine ≥0.05 ng/mL. NS were defined as
those who responded ‘No’ to ‘Smoking at least 100 cigar-
ettes in lifetime’ AND ‘No’ to smoking cigarettes in last
5 days AND had cotinine <0.05 ng/mL.
Confounding variables
Age at interview in years was used as a continuous
variable. Gender was categorized as males and
females. Self-reported race/ethnicity was categorized as
non-Hispanic white, non-Hispanic black, Hispanic, and
other race. Physical activity was categorized as being
active if respondent answered ‘Yes’ to either the question
‘Over the past 30 days, did you do moderate activities for
at least 10 minutes that cause only light sweating or a
slight to moderate increase in breathing or heart rate?
Some examples are brisk walking, bicycling for pleasure,
golf, and dancing’ OR the question ‘Over the past
30 days, did you do any vigorous activities for at least
10 minutes that caused heavy sweating, or large increases
in breathing or heart rate? Some examples are running,
lap swimming, aerobics classes or fast bicycling’.
Participants were considered non-active if they answered
‘No’ to both questions mentioned above. Alcohol con-
sumption was surveyed and categorized as ≤1, 2–3, 4–5,
and ≥6 drinks per week.10 Education level was reported
as number of years of school attended and was categor-
ized into less than high school (less than 9th grade,
9–11 grade, 12th grade with no diploma), high school
(high school graduate/general education degree or
equivalent) and greater than high school (some college
or associate arts degree, college graduate or above).
Poverty income ratio (PIR) is an income-to-needs vari-
able measuring the ratio of household income to the US
poverty threshold for each respondent’s family size and
composition. PIR was used to determine whether the
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participant’s household income was < or ≥200% of the
federal poverty level (FPL).19 The year of the survey
cycle used in the analyses was every 2 years from 1999 to
2010. There were six cycles.
Statistical analyses
Descriptive statistics was used to characterize the subjects
(mean±SE) for continuous variables, and unweighted
number and weighted percent for categorical variables
in table 1. We used the log base (e) of BMI, HOMA-IR,
FPG, and HbA1c for the analyses as the original vari-
ables were not normally distributed. To test the statistical
differences between the smoking status-related groups in
the categorical variables of the sample characteristics, χ2
test for categorical variables was used. For the normally
distributed log-transformed continuous variables, we
used generalized linear model (GLM) and present the
unadjusted values in table 1. p<0.05 was considered stat-
istically significant.
A GLM was used to examine the association between
the outcome variables (log-transformed BMI, HOMA-IR,
FPG, and HbA1c) and smoking status, controlling for
age, gender, race/ethnicity, physical activity, education,
FPL, year of survey cycle, and alcohol consumption. We
estimated the adjusted mean and 95% CIs of log BMI,
HbA1c, HOMA-IR, and FPG among the three smoking
groups with non-smokers as the reference group. We
adjusted for physical activity and alcohol consumption
because it has been shown that smokers are less physic-
ally active20 and consume more alcohol than never
smokers.21 We also examined the association between
the outcome variables (log-transformed BMI, HOMA-IR,
FPG, and HbA1c) and cotinine groups, controlling for
age, gender, race/ethnicity, physical activity, education,
FPL, year of survey cycle, and alcohol consumption. We
estimated the adjusted mean and 95% CIs of log BMI,
HbA1c, HOMA-IR, and FPG among the cotinine groups
with low cotinine as the reference group. The above ana-
lyses were repeated in table 3 with BMI added as an add-
itional covariate in the model. We performed the
Sobel-Goodman mediation tests22 in STATAV.14.2 to test
the extent of how BMI influences the effect of SHS on
glycemic parameters.
We used multiple logistic regression models to obtain
the adjusted OR and SEs for the categorized outcome
variables (BMI 25–29.9 kg/m2, BMI≥30 kg/m2,
HOMA-IR≥2.2, FPG≥126 mg/dL, and HbA1c≥6.5%)
after controlling for age, gender, race/ethnicity, physical
activity, education, FPL, year of survey cycle, and alcohol
consumption. Data were presented as adjusted OR and
SE and p<0.05 was considered statistically significant. All
analyses were performed using SAS software V.9.4 (SAS
Institute, Cary, North Carolina, USA) and the survey
module of STATA software V.14.2 taking into consider-
ation the complex sampling design and the sampling
weights. Sample weights provided by the National
Center for Health Statistics (NCHS) were used to
correct for differential selection probabilities and to
adjust for non-coverage and non-response.
RESULTS
Of the 6472 participants with complete data used in the
study, using cotinine level-confirmed smoking status as
defined by the cotinine method above, 2835 (43.8%)
had low cotinine and were considered NS, 1759 (27.2%)
had medium cotinine and were considered SHSers, and
1878 (29.0%) had high cotinine and were considered
were CS (table 1). We could not define FS using this
method. Using the second method of survey results com-
bined with cotinine levels, 1839 (29.8%) were NS, 1158
(17.8%) were SHSers, 1681 (25.0%) were FS, and 1794
(27.4%) were CS. Table 1 shows the sample character-
istics and the outcome variables by the two methods of
cotinine level-confirmed smoking status. In general, the
percentage of current smokers was similar for the coti-
nine group defined by cotinine level and by survey/
cotinine definition. Gender, race/ethnicity, alcohol
consumption, physical activity, FPL, education, study
cycle, age, BMI, and HOMA-IR and FPG varied signifi-
cantly by cotinine level-confirmed smoking status
(p<0.05) (table 1). Among the male subjects, 30% were
SHSers by cotinine level and 19.2% by survey/cotinine
definition, while among female subjects, 24.5% were
SHSers by cotinine level and 16.3% by survey/cotinine
definition. Blacks had the highest percentage of being
SHSers; 35% by cotinine level and 30.5% by survey/coti-
nine definition compared with all other race/ethnic
groups. Among participants with higher consumption of
alcohol (six or more drinks per day), 25.9% were
SHSers by cotinine level and 16.3% by survey/cotinine
definition, whereas 56.7% were CS by cotinine level and
56.6% by survey/cotinine definition. Among participants
with low income (FPL<200%), 28.4% were SHSers by
cotinine level and 20.2% by survey/cotinine definition
and among those with FPL≥200%, 26.8% were SHSers
by cotinine level and 16.9% by survey/cotinine defin-
ition. The percentage of participants who were classified
as SHSers defined by cotinine level decreased from
29.9% in 1999–2000 to 22.3% in 2009–2010 (F(5,87)
=3.77, p=0.004) and by survey/cotinine definition
decreased from 22.3% in 1999–2000 to 13.5% in 2009–
2010 (F(5,83)=8.54, p=0.0001). The percentage of parti-
cipants who were classified as NS defined by cotinine
level increased from 33.5% in 1999–2000 to 56.4% in
2009–2010 (F(5,87)=8.96, p=0.0001) and by survey/coti-
nine definition increased from 19.9% in 1999–2000 to
38.4% in 2009–2010 (F(5,87)=8.95, p=0.0001).
Using the survey/cotinine definition and unadjusted
means (to describe the sample), SHSers and CS were
younger and FS were older than NS and using cotinine
levels, CS and SHSers were younger than NS. Using
both definitions, SHSers had a higher BMI and
HOMA-IR than NS (table 1). By the survey/cotinine def-
inition, SHSers had a higher FPG than NS. By both
4 BMJ Open Diabetes Research and Care 2017;5:e000324. doi:10.1136/bmjdrc-2016-000324
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Table 1 NHANES 1999–2010 sample characteristics (N=6472)
Variables
Total
N (%)
Cotinine levels
N (%)
Cotinine level-confirmed smoking status
N (%)
High
cotinine
1878 (29.0)
Medium
cotinine
1759 (27.2)
Low
cotinine
2835 (43.8)
Current
smokers
1794 (27.4)
Former
smokers
1681 (25.0)
Secondhand
smokers
1158 (17.8)
Non-smokers
1839 (29.8)
Gender
Male 3352 (50.0) 1092 (31.4)* 953 (30.0)* 1307 (38.6) 1045 (30.4)† 938 (25.7)† 604 (19.2)† 765 (24.8)
Female (reference) 3120 (50.0) 786 (25.2) 806 (24.5) 1528 (50.3) 749 (24.5) 743 (24.3) 554 (16.3) 1074 (34.8)
Race/ethnicity
White (reference) 3495 (74.6) 952 (27.0) 924 (26.8) 1619 (46.2) 926 (26.5) 1098 (27.9) 507 (15.7) 964 (29.9)
Black 1094 (9.0) 441 (40.5)* 392 (35.0)* 261 (24.5) 418 (38.3)† 161 (11.6)† 317 (30.5)† 198 (19.6)
Hispanic 1238 (7.6) 299 (24.7) 267 (22.1)* 672 (53.2) 271 (22.7)† 293 (19.9)† 196 (17.4) 478 (39.9)
Other Hispanic 399 (4.0) 106 (27.7) 111 (27.3) 182 (45.0) 103 (26.8) 78 (17.1)† 90 (24.0) 128 (32.1)
Other 246 (4.8) 80 (32.0) 65 (27.8) 101 (40.2) 76 (30.3) 51 (18.9) 48 (21.4) 71 (29.5)
Alcohol consumption (drinks per day)
≤1 (reference) 2316 (35.3) 334 (13.9) 593 (25.3) 1389 (60.8) 314 (13.3) 674 (27.6) 390 (16.5) 938 (42.6)
2–3 2658 (43.4) 784 (28.0)* 772 (28.7)* 1102 (43.2) 739 (26.9)† 747 (26.9)† 500 (18.6)† 672 (27.7)
4–5 741 (11.2) 354 (49.0)* 201 (28.7)* 186 (22.3) 341 (47.7)† 135 (17.8)† 143 (19.9)† 122 (14.6)
≥6 757 (10.1) 406 (56.7)* 193 (25.9)* 158 (17.4) 400 (56.6)† 125 (15.7)† 125 (16.3)† 107 (11.4)
Physical activity
Active (reference) 3834 (65.6) 911 (23.5) 1096 (28.0) 1827 (48.5) 866 (22.6) 1048 (25.9) 733 (18.8) 1187 (32.7)
Non-active 2638 (34.4) 967 (37.5)* 663 (25.8) 1008 (36.7) 928 (36.7)† 633 (23.3)† 425 (15.8) 652 (24.2)
CRP
<0.5 (reference) 4997 (79.5) 1429 (27.9) 1354 (27.1) 2214 (45.0) 1366 (27.3) 1268 (24.1) 912 (17.9) 1451 (30.7)
≥0.5 1475 (20.5) 449 (29.7) 405 (27.7 621 (42.6) 428 (28.0) 413 (28.3)† 246 (17.4) 388 (26.2)
Federal poverty level
<200% 2494 (27.1) 1042 (42.8)* 654 (28.4)* 798 (28.8) 1006 (41.9) 495 (17.4) 459 (20.2) 534 (20.5)
≥200% (reference) 3978 (72.9) 836 (22.9) 1105 (26.8) 2037 (50.3) 788 (22.1)† 1186 (27.8) 699 (16.9)† 1305 (33.2)
Education
Less than high school 1507 (14.4) 632 (47.4)* 385 (26.8)* 490 (25.8) 593 (45.2)† 352 (20.2)† 262 (18.2)† 300 (16.4)
High School 1489 (22.7) 549 (39.4)* 435 (30.0)* 505 (30.6) 529 (38.5)† 344 (21.8)† 286 (19.4)† 330 (20.3)
More than high school (reference) 3476 (62.9) 697 (19.9) 939 (26.3) 1840 (53.7) 672 (19.4) 985 (27.2) 610 (17.1) 1209 (36.3)
Year of survey cycle
1999–2000 653 (3.2) 193 (29.9) 229 (36.6)* 231 (33.5) 186 (30.3)† 176 (27.5)† 142 (22.3)† 149 (19.9)
2001–2002 1148 (5.9) 350 (31.9)* 311 (27.9)* 487 (40.1) 339 (31.5)† 309 (25.0)† 204 (18.9)† 296 (24.6)
2003–2004 979 (20.7) 290 (30.0)* 299 (31.0)* 390 (39.0) 275 (29.1)† 265 (24.4)† 192 (20.6)† 247 (25.9)
2005–2006 1047 (23.0) 305 (30.6)* 308 (28.3)* 434 (41.1) 287 (29.3)† 273 (25.6)† 203 (18.0)† 284 (27.0)
2007–2008 1236 (23.3) 377 (28.6)* 318 (28.5)* 541 (42.9) 361 (28.0)† 308 (23.8) 211 (18.5)† 356 (29.7)
2009–2010 (reference) 1409 (24.0) 363 (23.3) 294 (20.3) 752 (56.4) 346 (22.3) 350 (25.7) 206 (13.5) 507 (38.4)
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definitions, CS had a lower BMI than NS, but similar
HOMA-IR, HbA1c, and FPG as NS. By the survey/coti-
nine definition, FS had higher HOMA-IR, HbA1c, and
FPG compared with NS.
Table 2 shows the adjusted mean and 95% CI of BMI,
HOMA-IR, HbA1c, and FPG by the GLM using the coti-
nine levels, and survey/cotinine definitions of smoking
groups after controlling for age, gender, race/ethnicity,
physical activity, education, FPL, year of survey cycle, and
alcohol consumption. Using cotinine levels, the adjusted
mean BMI in the medium cotinine group (SHS)
(28.2 kg/m2, 95% CI 27.9 to 28.5) was higher compared
with the low cotinine group (NS) (27.6 kg/m2, 95% CI
27.3 to 27.9 kg/m2; p=0.02). The adjusted mean
HOMA-IR was found to be higher in the group with
medium cotinine levels (SHSers) (2.31, 95% CI 2.20 to
2.42; p=0.004) and lower in the group with high cotinine
levels (CS) (1.85, 95% CI 1.75 to 1.94; p=0.002) com-
pared with the group with low cotinine levels (NS)
(2.09, 95% CI 2.0 to 2.18). The group with high cotinine
levels (CS) had higher levels of HbA1c (5.38%, 95% CI
5.35% to 5.40%; p<0.001) as did the medium cotinine
group (SHSers) (5.37%, 95% CI 5.34% to 5.39%;
p<0.001) than the group with low cotinine levels (NS)
(5.32%, 95% CI 5.30% to 5.34%). Higher levels of FPG
were found in the group with medium cotinine levels
(SHSers) (99.0 mg/dL, 95% CI 98.1 to 99.9; p=0.04),
but not in the group with high cotinine levels (CS)
(97.6 mg/dL, 95% CI 96.9 to 98.4; p=NS), compared
with the group with low cotinine levels (NS) (97.8 mg/
dL, 95% CI 97.1 to 98.6 mg/dL).
Using the survey/cotinine definition, the CS group
had lower adjusted BMI (26.2 kg/m2, 95% CI 25.9 to
26.6 kg/m2; p<0.0001) and the SHSers group had a
higher adjusted BMI (28.29 kg/m2, 95% CI 27.9 to
28.7 kg/m2; p=0.008) than the NS (27.5 kg/m2, 95% CI
27.1 to 27.89 kg/m2). Adjusted HOMA-IR was higher in
the SHSers group (2.31 mg/iU, 95% CI 2.16–2.47 mg/
iU; p=0.004) and the FS group (2.24 mg/iU, 95% CI
2.13 to 2.35 mg/iU; p=0.004) and lower in the CS group
(1.82 mg/iU, 95% CI 1.73 to 1.92 mg/iU; p=0.004) com-
pared with the NS group (2.04 mg/iU, 95% CI 1.94 to
2.15 mg/iU). The adjusted mean HbA1c was similar
among the SHSers group (5.38%, 95% CI 5.35% to
5.41%, p=0.001) and CS group (5.38%, 95% CI 5.35%
to 5.40%, p=0.001) but higher compared with the NS
group (5.31%, 95% CI 5.29% to 5.34%). FPG in the
SHSers group (99.5 mg/dL, 95% CI 98.5 to 100.5 mg/
dL; p=0.002) was higher compared with the NS
(97.5 mg/dL, 95% CI 96.6 to 98.3 mg/dL).
Table 3 shows the effect of adjusting for BMI, in add-
ition to the above variables, on relationship between
smoking status and glycemic indices. After controlling
for BMI, HOMA-IR in the high cotinine group and CS
and SHSer group, and FPG in the medium cotinine
group were no longer statistically significant. We tested
the extent of how BMI influences the effect of medium
cotinine (table 3, third column) on glycemic parametersV
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Table 2 Adjusted mean (95% CI) of BMI, HOMA-IR, HbA1c, and FPG according to cotinine levels, and cotinine level-confirmed smoking status for participants ≥20 years old (N=6472) without
adjusting for BMI
*High cotinine
1878 (29.0%)
*Medium cotinine
1759 (27.2%)
Low cotinine
2835 (43.8%)
†Current smoker
1794 (27.4%)
†Former smoker
1681 (25.0%)
†Secondhand smoker
1158 (17.8%)
Non-smoker
1839 (29.8%)
BMI (kg/m2) 26.3 (26.0 to 26.6)‡ 28.2 (27.9 to 28.5)‡ 27.6 (27.2 to 27.9) 26.2 (25.9 to 26.6)‡ 27.9 (27.5 to 28.2) 28.3 (27.9 to 28.7)‡ 27.5 (27.1 to 27.9)
Waist circumference
(cm)
93.17 (92.35 to 94.00)‡ 97.32 (96.60 to 98.04)‡ 95.29 (94.41 to 96.16) 92.91 (92.01 to 93.80)‡ 96.78 (95.80 to 97.76)‡ 97.32 (96.27 to 98.38)‡ 94.87 (93.88 to 95.85)
HOMA-IR (mg/iU) 1.85 (1.75 to 1.94)‡ 2.31 (2.20 to 2.42)‡ 2.09 (2.00 to 2.18) 1.82 (1.73 to 1.92)‡ 2.24 (2.13 to 2.35)‡ 2.31 (2.16 to 2.47)‡ 2.04 (1.94 to 2.15)
HbA1c (%) 5.38 (5.35 to 5.40)‡ 5.37 (5.34 to 5.39)‡ 5.32 (5.30 to 5.34) 5.38 (5.35 to 5.40)‡ 5.34 (5.31 to 5.36) 5.38 (5.35 to 5.41)‡ 5.31 (5.29 to 5.34)
FPG (mg/dL) 97.64 (96.88 to 98.40) 99.00 (98.11 to 99.90)‡ 97.84 (97.11 to 98.57) 97.41 (96.63 to 98.20) 98.62 (97.69 to 99.55) 99.51 (98.51 to 100.51)‡ 97.46 (96.64 to 98.29)
Data are presented as mean (95% CI). Adjusted for age, sex, races, C reactive protein, alcohol, physical activity, education, poverty level, and year of survey cycle.
*Reference is low cotinine.
†Reference is non-smoker.
‡Statistically significant at p<0.05.
BMI, body mass index; FPG, fasting plasma glucose; HbA1c, hemoglobin A1c; HOMA-IR, Homeostasis Model Assessment of Insulin Resistance.
Table 3 Adjusted mean (95% CI) of HOMA-IR, HbA1c, and FPG according to cotinine levels, and cotinine level-confirmed smoking status for participants ≥20 years old
(N=6472) with adjustment for BMI
*High cotinine
1878 (29.0%)
*Medium cotinine
1759 (27.2%)
Low cotinine
2835 (43.8%)
†Current smoker
1794 (27.4%)
†Former smoker
1681 (25.0%)
†Secondhand
smoker
1158 (17.8%)
Non-smoker
1839 (29.8%)
HOMA-IR (mg/iU) 2.02 (1.94 to 2.10) 2.17 (2.08 to 2.25)‡ 2.05 (1.97 to 2.13) 2.00 (1.92 to 2.08) 2.16 (2.05 to 2.26)‡ 2.15 (2.04 to 2.27) 2.02 (1.92 to 2.11)
HbA1c (%) 5.39 (5.37 to 5.42)‡ 5.35 (5.33 to 5.38)‡ 5.32 (5.30 to 5.33) 5.39 (5.37 to 5.42)‡ 5.33 (5.30 to 5.36) 5.37 (5.34 to 5.40)‡ 5.31 (5.29 to 5.33)
FPG (mg/dL) 98.3 (97.5 to 99.0) 98.5 (97.7 to 99.4) 97.7 (97.0 to 98.4) 98.1 (97.3 to 98.9) 98.3 (97.4 to 99.3) 99.0 (98.0 to 99.9)‡ 97.4 (96.7 to 98.1)
Data are presented as mean (95% CI). Adjusted for age, sex, races, BMI, C reactive protein, alcohol, physical activity, education, poverty level, and year of survey cycle.
Values in bold indicate changed statistical significance compared with table 2.
*Reference is low cotinine.
†Reference is non-smoker.
‡Statistically significant at p<0.05.
BMI, body mass index; FPG, fasting plasma glucose; HbA1c, hemoglobin A1c; HOMA-IR, Homeostasis Model Assessment of Insulin Resistance.
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and found that the proportion of total effect that is
mediated by BMI is 0.62 on HOMA-IR, 0.73 on FPG,
and 0.53 on HbA1c. The effect of SHS (table 3, seventh
column) that is mediated by BMI is 0.69 on HOMA-IR,
0.41 on FPG, and 0.42 on HbA1c.
Figure 2 shows the use of a multivariate logistic regres-
sion to examine the association between the outcomes
and the smoking status determined by the survey/
cotinine definition controlling for the confounding
variables (age, gender, race/ethnicity, physical activity,
education, FPL, year of survey cycle, and alcohol
consumption). SHSers had higher adjusted odds
of FPG≥126 mg/dL (OR=2.2, SE=0.6; p=0.01) and
HOMA-IR≥2.2 (OR=1.4, SE=0.1; p=0.001) relative to NS.
CS had lower odds of BMI≥30 kg/m2 (OR=0.60, SE=0.1;
p<0.01) and BMI 25–29.9 kg/m2 (OR=0.66, SE=0.1;
p< 0.01) compared with NS. SH had greater odds of
BMI≥30 kg/m2 (OR=1.5, SE=0.2; p=0.01) and BMI
25–29.9 kg/m2 (OR=1.3, SE=0.1; p=0.01) compared with
NS. FS also had higher adjusted odds of BMI≥30 kg/m2
(OR=1.4, SE=0.2; p=0.01), but was not significant for
BMI 25–29.9 kg/m2 (OR=1.2, SE=0.1; p=0.1). FS also
had higher adjusted odds of HOMA-IR≥2.2 (OR=1.3,
SE=0.1; p=0.01). The adjusted odds of HbA1c≥6.5%
was not statistically different for all groups compared
with NS.
Figure 3 shows the use of a multivariate logistic regres-
sion to examine the association between the outcomes
(BMI, HOMA, HbA1c, and FPG) and the smoking status
determined by cotinine levels controlling for the same
confounding variables. CS (high cotinine level) had a
lower adjusted OR of having a BMI≥30 kg/m2
(OR=0.57, SE=0.1; p<0.001) and BMI 25–29.9 kg/m2
(OR=0.67, SE=0.1; p< 0.001) relative to NS (with a low
cotinine level). SHS (medium cotinine level) had a
higher adjusted OR of having a BMI≥30 kg/m2
(OR=1.4, SE=0.2; p=0.009) and BMI 25–29.9 kg/m2
(OR=1.3, SE=0.1; p=0.004) relative to NS (with a low
cotinine level). SHS (medium cotinine level) had a
higher adjusted OR of having a HOMA-IR≥2.2 (OR=1.3,
SE=0.1; p<0.0001) relative to NS (with a low cotinine
level). The adjusted ORs of having an HbA1c≥6.5% or
Figure 2 Adjusted OR and SE for BMI≥30 kg/m2, BMI 25–29.9 kg/m2, HbA1c≥6.5%, HOMA-IR≥2.2, and FPG≥126 mg/dL in
CS, FS, and SHS using the survey/cotinine definition compared with the reference group of NS after adjusting for age, sex,
races, alcohol, physical activity, education, FPL, year of survey cycle using multiple logistic regression. *p<0.05. BMI, body mass
index; CS, current smokers; FPG, fasting plasma glucose; FS, former smokers; HbA1c, hemoglobin A1c; HOMA-IR,
Homeostasis Model Assessment of Insulin Resistance; SHS, secondhand smokers.
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FPG≥126 mg/dL were not statistically different for all
groups compared with the NS (low cotinine level).
DISCUSSION
This is the first study, to the best of our knowledge, that
has examined the relationship between secondhand
smoking and glycemic parameters and obesity using
both recent self-reported cigarette smoking status and
race/ethnicity-corrected cotinine values to define
secondhand smoking. Our most significant finding is
that using both methods of defining SHSers, we found
that SHS exposure was associated with higher adjusted
levels of HOMA-IR, FPG, and HbA1c as well as higher
BMI, while CS is associated with a lower BMI compared
with non-smokers. Adjustment for BMI demonstrated
that some, but not all of the detrimental effects of SHS
on glycemia are mediated by the increased weight of
SHSer. The effects of SHS on HOMA-IR, a glycemic par-
ameter, especially related to obesity, was especially
reduced when adjusting for BMI.
The present findings are consistent with the results of
a recent meta-analysis examining prospective cohort
studies on passive smoking that showed a significant rela-
tive risk of developing DM.11 This meta-analysis assessed
four publications that all defined passive smoking by
history and found a pooled relative risk (RR) of 1.28
(95% CI 1.14 to 1.44). The CARDIA study,23 a prospect-
ive cohort study, is noteworthy in that they did confirm
SHS exposure by measuring serum cotinine levels and
found that those with passive exposure to tobacco smoke
verified by cotinine levels had an intermediate risk for
developing glucose intolerance between current
smokers and never smokers without passive smoke
exposure. This study did not examine the incidence of
obesity. Also, the CARDIA study was done among black
and white young adults aged 18–30 years, whereas our
study looked at all race/ethnicity and adults over
20 years.
Several cross-sectional studies have shown an associ-
ation between passive smoking with the development of
Figure 3 Adjusted OR and SE for BMI≥30 kg/m2, BMI 25–29.9 kg/m2, HbA1c≥6.5%, HOMA-IR≥2.2, and FPG≥126 mg/dL in
those with high cotinine levels (CS) and medium cotinine levels (SHS) compared with the reference group of low cotinine levels
(NS) after adjusting for age, sex, races, alcohol, physical activity, education, FPL, year of survey cycle using multiple logistic
regression. *p<0.05. BMI, body mass index; FPG, fasting plasma glucose; HbA1c, hemoglobin A1c; HOMA-IR, Homeostasis
Model Assessment of Insulin Resistance.
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type 2 DM.23–26 Lajous et al showed an association
between SHS and DM in a prospective setting, but the
study was done only in female Caucasians, thus the
results cannot be generalized to men or non-Caucasian
populations.25 Furthermore, this study used self-report
SHS exposure that was not verified by cotinine levels.
Zhang et al26 found that there was a positive relationship
between exposure to passive smoke and active smoking
and the risk of developing type 2 DM. This study, which
confirms our findings of the association between
secondhand smoking and DM, was a prospective study
with high follow-up rates, although DM was only by self-
report. In our study, we used biochemical parameters to
define DM and other glycemic parameters. The study by
Zhang et al26 included mainly white females, thus the
results and conclusions cannot be generalized to the
entire population since the study was not on a national
representative sample. Our study used the NHANES
database and thus our results can be generalized to the
non-institutionalized population. In addition, passive
smokers in study by Zhang et al26 were based on self-
report. A prospective study by Hayashino et al27 showed
that self-reported exposure to SHS in the workplace and
current active smoking at baseline were positively asso-
ciated with an increased risk of developing DM, even
after controlling for possible confounders consistent
with the findings of our study.
Studies of users of nicotine gum have higher rates of
insulin resistance28 and therefore, it is believed that the
nicotine in cigarettes is the component that is associated
with a higher rate of DM. We found that SHSers who are
involuntarily exposed to cigarette smoking, had higher
rates of two conditions, DM and obesity, that are asso-
ciated with high mortality and morbidity. It is possible
that the hand-to-mouth action of cigarettes, or the effect
of cigarettes on taste buds, conditions that are not
present for SHSers, may lead to CS being leaner than
SHSers. Although one can argue that CS are also
exposed to SHS, we are not surprised that CS are leaner
than SHSers for several reasons. While SHSers are
exposed to less smoke than CS, we do not know the
dose relationship between amount of smoke and its
effects on DM. SHS is produced at different tempera-
tures and different reducing conditions, so some toxic
substances may occur in different concentrations in SHS
compared to primary smoke. Finally, the filter of cigar-
ettes may decrease some of the negative effects of smoke
in CS, but not SHSers.3 29 30
We found a statistical difference in genders between
SHSers and NS that could be due to exposure of male
subjects to more environmental smoke compared with
female subjects. Males may be working in industries or
in bars where more people smoke. There was a higher
percentage of SHSers among blacks compared to whites
that could be due to the disparities in occupations, with
blacks being disproportionately employed in laborer and
factory jobs. Although the national average of those in
the laborer and factory jobs is 27%, the percent of
blacks in those jobs is 41%.31 According to the Praxis
Project, an analysis of municipal tobacco control ordi-
nances in the USA found that communities with signifi-
cant numbers of people of color are less likely to have
any municipal tobacco control ordinances in place when
compared with communities with fewer people of
color.32 Non-Hispanic blacks metabolize cotinine slower
than other racial/ethnic groups resulting in a higher
cotinine level for the same amount of tobacco used.33
We found that there was a higher percentage of
SHSers among those who had four or more alcohol
drinks per day compared with NS. Those who drink
more and thus visit bars and pubs are more exposed to
SHS compared to those who have fewer drinks per day.
According to the US Department of Health and Human
Services, levels of SHS in restaurants and bars were
found to be two to five times higher than in residences
with smokers and two to six times higher than in office
workplaces.34
Most interestingly, using both our definitions of
smoking status, there was a decline in the rates of SHS
in each 2-year iteration of the NHANES survey. This con-
firms a recent report using higher cut-offs of cotinine
than we did to define SHSers and found that SHS
smoke exposure in non-smokers declined from 52.5%
during 1999–2000 to 25.3% during 2011–2012.35 Our
data showed that SHS exposure declined from 22.3%
during 1999–2000 to 13.5% during 2009–2010. We, as
well as Homa et al,35 posit that this decline is related to
introduction of statewide indoor smoking restriction
laws during this time. According to the American
Nonsmokers’ Rights Foundation (http://www.no-smoke.
org), in 2016, across the USA, 22 590 municipalities,
representing 82.1% of the US population, are covered
by a 100% smoke-free provision in non-hospitality work-
places, and/or restaurants, and/or bars, by either a
state, commonwealth, territorial, or local law. Forty-one
states and the District of Columbia have local laws in
effect that require non-hospitality workplaces and/or
restaurants and/or bars to be 100% smoke-free. The
decline in rates of SHSers between 1999–2000 and
2009–2010 demonstrate that smoke-free laws are effect-
ive and may help decrease the number of Americans
who develop obesity and DM as a result of being
exposed to SHS. However, with several states without
smoke-free laws, our data support the need for more
states to pass smoke-free legislation. Laws prohibiting
smoking in multiunit housing, including public housing,
would further decrease the consequences of SHS.
Although it is unknown if there will be lag time between
the decline in SHS exposure and the potential decline
in detrimental glycemic parameters and obesity, the
effect of smoke-free laws on other health parameters is
rapid, with immediate improvements in heart disease
and improvements in lung cancer in about 2 years.36
Thus, we are optimistic that there will be a decline in
SHS-associated DM and obesity in the near future that
will continue with further reduction in SHS.
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Strengths and limitations
Our study had several limitations. Since the NHANES
data are a cross-sectional study, we cannot assess a causal
relationship, although our results are consistent with
several prospective cohort studies,23 24 26 37 which did
show that SHS exposure led to the development of
glucose intolerance and DM. Also, although we con-
trolled for major confounders and found a robust associ-
ation, it is possible that other unknown confounders
could account for the association between secondhand
smoking and DM and obesity. Cotinine levels decrease
with time following the last exposure, so measurement
of cotinine only reflects recent exposure.
We defined CS, SHSers, and NS in two manners as dis-
cussed in the Research design and methods section
using survey/cotinine definition and the objective
race-ethnicity-adjusted measurement of serum cotinine
levels. For the most part, the characterization by survey/
cotinine definition was consistent with that by cotinine
levels. However, it is possible that participants did not
answer the surveys correctly (recall bias) as studies have
shown that self-report underestimates smoking status.38
Those defined as SHSers by cotinine could be CS who
did not smoke in the few days before the sample was col-
lected, never smokers exposed to SHS, or FS exposed to
SHS. Glycemic abnormalities and obesity develop over
time, so using current cotinine levels may not reflect
what happened decades ago when the pathogenesis of
these diseases began. We attempted to overcome this dif-
ficulty by examining FS using survey/cotinine definition
and found that these individuals had glycemic and
obesity outcomes that were intermediate between CS
and SHSers. FS can be currently exposed to SHS.
We only examined the association between smoking
status and body weight; in future studies, we may
examine the association between smoking status and fat
distribution, as visceral obesity is the key determinant of
the predilection to develop DM.
CONCLUSION
In summary, because the USA has witnessed widespread
increases in the prevalence of obesity and DM over the
past few decades leading to high health costs, our study
showing the association between cotinine-verified
SHSers and worsening of glycemic parameters as well as
obesity prompts the need for reliable and cost-effective
methods for interventions to prevent secondhand
smoking including stronger smoke-free laws. However,
the only true solution for the health consequences of
SHS exposure is a complete smoking ban.
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